Heartbeam Inc. Warrant (BEATW)
$0.01
$0.00
(13.59%)
As on 02-Sep-2026 15:28EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$132.45 Mln
EBITDA
$135.61 Mln
Net Profit
$41.75 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Heartbeam Inc. Warrant (BEATW)
| -96.3 | -26.9 | -80.5 | -96.0 | -69.2 | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Heartbeam Inc. Warrant (BEATW)
| -50.6 | 62.1 | -63.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Heartbeam Inc. Warrant (BEATW)
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company... develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California. Read more
-
Headquarters
--
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Heartbeam Inc. Warrant (BEATW)
What is the current share price of Heartbeam Inc Warrant (BEATW) Today?
The share price of Heartbeam Inc Warrant (BEATW) is $0.01 (NASDAQ) as of 02-Sep-2026 15:28 EDT. Heartbeam Inc Warrant (BEATW) has given a return of -69.18% in the last 3 years.
What is the current PB & PE ratio of Heartbeam Inc Warrant (BEATW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.51 |
4.14 |
2024 |
-0.89 |
10.49 |
2023 |
-0.72 |
0.66 |
2022 |
-0.68 |
3.68 |
2021 |
-1.32 |
0.44 |
What is the 52 Week High and Low of Heartbeam Inc Warrant (BEATW)?
The 52-week high and low of Heartbeam Inc Warrant (BEATW) are Rs 0.56 and Rs 0.01 as of 04-Sep-2026.
What is the market cap of Heartbeam Inc Warrant (BEATW)?
Heartbeam Inc Warrant (BEATW) has a market capitalisation of -- as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Heartbeam Inc Warrant (BEATW)?
Before investing in Heartbeam Inc Warrant (BEATW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.